Trends in Racial-Ethnic Disparities in Adult Mental Health Treatment Use From 2005 to 2019.
Trends in Racial-Ethnic Disparities in Adult Mental Health Treatment Use From 2005 to 2019.
复制标题
2005 年至 2019 年成人心理健康治疗使用中种族差异的趋势。
DOI:
10.1176/appi.ps.202100700
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Keyes,KatherineM
中科院分区:
文献类型:
--
作者:
Kaur,Navdep;Esie,Precious;Finsaas,MeganC;Mauro,PiaM;Keyes,KatherineM
ObjectiveAlthough U.S. mental health treatment rates increased in the 2000s, gaps in treatment among racial-ethnic groups grew. Little is known, however, about national trends after 2012, when treatment access increased overall. This study assessed trends in racial-ethnic disparities in past-year treatment rates among people with a major depressive episode, serious psychological distress, or serious mental illness.MethodsNational Survey on Drug Use and Health (2005–2019) data of adults with a past-year major depressive episode (N=49,791) or serious psychological distress (N=89,233) and of adults with past-year serious mental illness (N=24,944; 2008–2019) were analyzed. Linear risk regressions were used to model trends in past-year use of mental health treatment and included an interaction term between survey year and race-ethnicity.ResultsTreatment use prevalence (2005–2019) among marginalized individuals with a major depressive episode remained lower than that among White people. The magnitude of the disparity in treatment use between White and Hispanic people with major depressive episode decreased slightly (percentage-point difference=−25.1% to −14.9%), whereas the disparity in treatment use between White people and American Indian/Alaska Native people with serious mental illness increased significantly (percentage-point difference=23.4% to −12.2%), from 2005 to 2019. The magnitude of the disparities for other marginalized racial-ethnic groups did not meaningfully change.ConclusionsRacial-ethnic disparities in past-year mental health treatment use have persisted. Efforts to reduce disparities should consider structural barriers that hinder treatment use among marginalized groups.